Latest Insights on XPER

Today, I want to talk about a few of the most popular investing tools … as well as a brand-new investment strategy that I believe deserves your attention. It’s Time to Upgrade Your Investing Toolbox Today, I want to talk about a few of the most popular investing tools … as well as a brand-new investment strategy that I believe deserves your attention.
This Chart Proves It’s Time to Get Greedy [3-minute read] Turn fear into opportunities.
Make 35% by July 4 With Exxon Mobil
by John Ross February 5, 2020 American Investor Today, Oil
Wall Street is dumping this energy giant over a tough quarter. John Ross shares how to make 26% on Exxon's rally by Independence Day.
Wuhan virus is pushing internet stocks higher The Wuhan Virus Is Pushing These Stocks Higher [4-minute read] Don’t miss out on one of the best opportunities to ever come from this massive economy.
abbvie stock Profit From AbbVie’s Struggles Today Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Looks like I have finally found the right person to learn and grow from.”

- James

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

Share This